The new rules introduce a fast-track notification route, enabling quicker starts for lower-risk trials and maintaining safety ...

The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...

The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments ...